Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management

References

• Wong MCS, Huang JLW, George J, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16:57–73.30158570
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317–370.28620797
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Cho CS, Gonen M, Shia J, et al. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg. 2008;206:281–291. doi:10.1016/j.jamcollsurg.2007.07.03118222381
   PubMed Web of Science ®Google Scholar
• Huang S, Huang GQ, Zhu GQ, et al. Establishment and validation of SSCLIP scoring system to estimate survival in hepatocellular carcinoma patients who received curative liver resection. PLoS One. 2015;10:e0129000. doi:10.1371/journal.pone.012900026057656
   PubMed Web of Science ®Google Scholar
• Shim JH, Jun MJ, Han S, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261:939–946. doi:10.1097/SLA.000000000000074724950276
   PubMed Web of Science ®Google Scholar
• Li Y, Xia Y, Li J, et al. Prognostic nomograms for pre- and postoperative predictions of long-term survival for patients who underwent liver resection for huge hepatocellular carcinoma. J Am Coll Surg. 2015;221:962–74.e4. doi:10.1016/j.jamcollsurg.2015.08.00326382973
   PubMed Web of Science ®Google Scholar
• Shen J, He L, Li C, et al. Prognostic nomograms for patients with resectable hepatocellular carcinoma incorporating systemic inflammation and tumor characteristics. Oncotarget. 2016;7:80783–80793. doi:10.18632/oncotarget.1303827811374
   PubMedGoogle Scholar
• Li J, Zhou J, Yang PH, et al. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. Eur J Cancer. 2016;62:86–95. doi:10.1016/j.ejca.2016.04.01127232330
   PubMed Web of Science ®Google Scholar
• Yang P, Qiu J, Li J, et al. Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas. Ann Surg. 2016;263:778–786. doi:10.1097/SLA.000000000000133926135698
   PubMed Web of Science ®Google Scholar
• Hu H, Han XK, Long XR, et al. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma. Oncotarget. 2016;7:58302–58314. doi:10.18632/oncotarget.1107827506942
   PubMedGoogle Scholar
• Hsu CY, Liu PH, Hsia CY, et al. Surgical resection is better than transarterial chemoembolization for patients with hepatocellular carcinoma beyond the Milan Criteria: a prognostic nomogram study. Ann Surg Oncol. 2016;23(3):994–1002. doi:10.1245/s10434-015-4929-x26487000
   PubMed Web of Science ®Google Scholar
• Torzilli G, Donadon M, Belghiti J, et al. Predicting individual survival after hepatectomy for hepatocellular carcinoma: a novel nomogram from the “HCC East & West Study Group”. J Gastrointest Surg. 2016;20:1154–1162. doi:10.1007/s11605-016-3132-027003271
   PubMed Web of Science ®Google Scholar
• Fu YP, Ni XC, Yi Y, et al. A novel and validated Inflammation-Based Score (IBS) predicts survival in patients with hepatocellular carcinoma following curative surgical resection: a STROBE-Compliant article. Medicine (Baltimore). 2016;95:e2784. doi:10.1097/MD.000000000000278426886627
   PubMed Web of Science ®Google Scholar
• Feng LH, Dong H, Lau WY, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143:293–303. doi:10.1007/s00432-016-2286-127743138
   PubMed Web of Science ®Google Scholar
• Shen J, He L, Li C, et al. Nomograms to predict the individual survival of patients with solitary hepatocellular carcinoma after hepatectomy. Gut Liver. 2017;11:684–692. doi:10.5009/gnl1646528651303
   PubMed Web of Science ®Google Scholar
• Fu YP, Yi Y, Huang JL, et al. Prognostic nomograms stratify survival of patients with hepatocellular carcinoma without portal vein tumor thrombosis after curative resection. Oncologist. 2017;22:561–569. doi:10.1634/theoncologist.2016-023128438885
   PubMed Web of Science ®Google Scholar
• Zhang W, Tan Y, Shen S, et al. Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy. Oncotarget. 2017;8:106393–106404. doi:10.18632/oncotarget.1819229290957
   PubMedGoogle Scholar
• Jing CY, Fu YP, Zheng SS, et al. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine (Baltimore). 2017;96(11):e6140. doi:10.1097/MD.000000000000614028296727
   PubMed Web of Science ®Google Scholar
• Sun HC, Xie L, Yang XR, et al. Shanghai score: a prognostic and adjuvant treatment-evaluating system constructed for Chinese patients with hepatocellular carcinoma after curative resection. Chin Med J (Engl). 2017;130(22):2650–2660. doi:10.4103/0366-6999.21801929133751
   PubMed Web of Science ®Google Scholar
• Zheng BH, Liu LZ, Zhang ZZ, et al. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients. BMC Cancer. 2018;18(1):1148. doi:10.1186/s12885-018-5024-z30463529
   PubMed Web of Science ®Google Scholar
• Huang JL, Fu YP, Jing CY, et al. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection. J Surg Oncol. 2018;117:625–633. doi:10.1002/jso.2489529165812
   PubMed Web of Science ®Google Scholar
• Gan W, Yi Y, Fu Y, et al. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study. J Cancer. 2018;9:148–156. doi:10.7150/jca.2224629290780
   PubMed Web of Science ®Google Scholar
• Cai BB, Shi KQ, Li P, et al. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection. Clin Chim Acta. 2018;485:187–194. doi:10.1016/j.cca.2018.06.02029908940
   PubMed Web of Science ®Google Scholar
• Cao Y, Jiang Z, Wang S, Zhang H, Jiang Y, Lv L. Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma. Oncol Lett. 2018;15:2574–2582.29434976
   PubMed Web of Science ®Google Scholar
• Hu Y, You S, Yang Z, Cheng S. Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection. ANZ J Surg. 2019;89:E20–E25. doi:10.1111/ans.1470830117625
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun K, Shen J, et al. Novel prognostic nomograms based on inflammation-related markers for patients with hepatocellular carcinoma underwent hepatectomy. Cancer Res Treat. 2019;51:1464–1478. doi:10.4143/crt.2018.65730913869
   PubMed Web of Science ®Google Scholar
• Kim JM, Kwon CHD, Joh JW, et al. Nomograms in hepatectomy patients with hepatitis B virus-related hepatocellular carcinoma. J Gastrointest Surg. 2019;23:1559–1567.30671793
   PubMed Web of Science ®Google Scholar
• Chen L, Cai BB, Zhou CJ, et al. A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma. Cancer Manag Res. 2019;11:693–703. doi:10.2147/CMAR.S19359330679923
   PubMed Web of Science ®Google Scholar
• Lin ZX, Ruan DY, Jia CC, et al. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. Clin Transl Oncol. 2020;22:370–380. doi:10.1007/s12094-019-02137-431201606
   PubMed Web of Science ®Google Scholar
• Huang ZY, Liang BY, Xiong M, et al. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol. 2012;19:2515–2525. doi:10.1245/s10434-012-2269-722395985
   PubMed Web of Science ®Google Scholar
• Ochiai T, Ikoma H, Okamoto K, et al. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World J Surg. 2012;36:136–143. doi:10.1007/s00268-011-1317-y22051887
   PubMed Web of Science ®Google Scholar
• Meniconi RL, Komatsu S, Perdigao F, Boëlle PY, Soubrane O, Scatton O. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection. Surgery. 2015;157:454–462. doi:10.1016/j.surg.2014.10.01125633732
   PubMed Web of Science ®Google Scholar
• Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261:947–955. doi:10.1097/SLA.000000000000071025010665
   PubMed Web of Science ®Google Scholar
• Notake T, Kobayashi A, Shinkawa H, et al. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection. Int J Clin Oncol. 2017;22:715–725. doi:10.1007/s10147-017-1114-128303401
   PubMed Web of Science ®Google Scholar
• He W, Peng B, Tang Y, et al. Nomogram to predict survival of patients with recurrence of hepatocellular carcinoma after surgery. Clin Gastroenterol Hepatol. 2018;16:756–64.e10. doi:10.1016/j.cgh.2017.12.00229246702
   PubMed Web of Science ®Google Scholar
• Saito R, Amemiya H, Hosomura N, et al. Prognostic factors for post-recurrent survival in hepatocellular carcinoma after curative resection. Anticancer Res. 2019;39(6):3033–3038. doi:10.21873/anticanres.1343631177145
   PubMed Web of Science ®Google Scholar
• Xiao H, Chen ZB, Jin HL, et al. Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy. Am J Transl Res. 2019;11:1864–1875.30972210
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022. doi:10.1002/hep.2419921374666
   PubMed Web of Science ®Google Scholar
• Kao WY, Chiou YY, Hung HH, et al. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur J Gastroenterol Hepatol. 2011;23:528–536.21537128
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Surgery. 2015;157:699–707. doi:10.1016/j.surg.2014.10.02225704421
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550–558. doi:10.1200/JCO.2014.57.915125512453
   PubMed Web of Science ®Google Scholar
• Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65:1369–1376. doi:10.1136/gutjnl-2015-30926026109530
   PubMed Web of Science ®Google Scholar
• Kamarajah SK, Frankel TL, Sonnenday C, Cho CS, Nathan H. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): a Surveillance, Epidemiology, End Results (SEER) analysis. J Surg Oncol. 2018;117:644–650. doi:10.1002/jso.2490829127719
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
   PubMed Web of Science ®Google Scholar
• Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(1691–700):e3.
   Google Scholar
• Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462–503. doi:10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E13160935
   PubMed Web of Science ®Google Scholar
• Cong WM, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22:9279–9287. doi:10.3748/wjg.v22.i42.927927895416
   PubMed Web of Science ®Google Scholar
• Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C The French METAVIR Cooperative Study Group. Hepatology. 1994;20:15–20. doi:10.1002/hep.18402001048020885
   PubMed Web of Science ®Google Scholar
• Couinaud C. Anatomic principles of left and right regulated hepatectomy: technics (in French). J Chir (Paris). 1954;70:933–966.13233306
   PubMedGoogle Scholar
• Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford). 2013;15:31–39. doi:10.1111/j.1477-2574.2012.00552.x23216777
   PubMed Web of Science ®Google Scholar
• DeOliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–939. doi:10.1097/01.sla.0000246856.03918.9a
   Web of Science ®Google Scholar
• Poon RT. Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies. Ann Surg Oncol. 2009;16:792–794. doi:10.1245/s10434-009-0330-y19190964
   PubMed Web of Science ®Google Scholar
• Wang Q, Lin L, Yoo S, et al. Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence. Br J Cancer. 2016;115:841–847. doi:10.1038/bjc.2016.23927537392
   PubMed Web of Science ®Google Scholar
• Erridge S, Pucher PH, Markar SR, et al. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma. Br J Surg. 2017;104:1433–1442. doi:10.1002/bjs.1059728628947
   PubMed Web of Science ®Google Scholar
• Wen T, Jin C, Facciorusso A, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr. 2018;7:353–371. doi:10.21037/hbsn.2018.08.0130498711
   PubMed Web of Science ®Google Scholar
• Lou J, Li Y, Liang K, et al. Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multi-center analysis. BMC Cancer. 2019;19:668. doi:10.1186/s12885-019-5870-331277593
   PubMed Web of Science ®Google Scholar
• Sun P, Li Y, Chang L, Tian X. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019;98:e15603. doi:10.1097/MD.000000000001560331083251
   PubMed Web of Science ®Google Scholar